These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9608398)

  • 1. Influence of the preparation methods on the drug release behaviour of loperamide-loaded nanoparticles.
    Ueda M; Iwara A; Kreuter J
    J Microencapsul; 1998; 15(3):361-72. PubMed ID: 9608398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of the preparation of loperamide-loaded poly (L-lactide) nanoparticles by high pressure emulsification-solvent evaporation.
    Ueda M; Kreuter J
    J Microencapsul; 1997; 14(5):593-605. PubMed ID: 9292435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres.
    Xu FH; Zhang Q
    Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles.
    Panyam J; Williams D; Dash A; Leslie-Pelecky D; Labhasetwar V
    J Pharm Sci; 2004 Jul; 93(7):1804-14. PubMed ID: 15176068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.
    O'Donnell A; Moollan A; Baneham S; Ozgul M; Pabari RM; Cox D; Kirby BP; Ramtoola Z
    J Pharm Pharmacol; 2015 Apr; 67(4):525-36. PubMed ID: 25515568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.
    Budhian A; Siegel SJ; Winey KI
    Int J Pharm; 2007 May; 336(2):367-75. PubMed ID: 17207944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ion pairing approach to increase the loading of hydrophilic and lipophilic drugs into PEGylated PLGA nanoparticles.
    Dalwadi G; Sunderland B
    Eur J Pharm Biopharm; 2009 Feb; 71(2):231-42. PubMed ID: 18768159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile.
    Ishihara T; Izumo N; Higaki M; Shimada E; Hagi T; Mine L; Ogawa Y; Mizushima Y
    J Control Release; 2005 Jun; 105(1-2):68-76. PubMed ID: 15955367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression.
    Prabha S; Labhasetwar V
    Pharm Res; 2004 Feb; 21(2):354-64. PubMed ID: 15032319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled association and delivery of nanoparticles from jet-sprayed hybrid microfibrillar matrices.
    Keloglu N; Verrier B; Trimaille T; Sohier J
    Colloids Surf B Biointerfaces; 2016 Apr; 140():142-149. PubMed ID: 26752211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of preparing two polylactide nanoparticles loaded lipophilic anti-cancer herb drug by nanoprecipitation method].
    Zhang JF; Hou SX; Liu HL
    Zhongguo Zhong Yao Za Zhi; 2007 Feb; 32(4):303-6. PubMed ID: 17455462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of poly(DL-lactide-co-glycolide) nanoparticles for preparation of mini-depot tablets by direct compression.
    Murakami H; Kobayashi M; Takeuchi H; Kawashima Y
    J Control Release; 2000 Jun; 67(1):29-36. PubMed ID: 10773326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
    Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
    Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles?
    Wichert B; Rohdewald P
    J Microencapsul; 1993; 10(2):195-207. PubMed ID: 8392542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The preparation of the polylacticacid nanoparticles of cucurbitacin and their drug loading].
    Zhang JF; Hou SX; Liu HL; Wang L; Hu P; Ye LM; Wang GS
    Zhongguo Zhong Yao Za Zhi; 2005 Mar; 30(6):436-9. PubMed ID: 15810448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.